Cell-free DNA blood-based test compared to fecal immunochemical test for colorectal cancer screening

Teresa Seum; Michael Hoffmeister; Hermann Brenner

doi:10.1002/cac2.70037

Cancer Communications ›› 2025, Vol. 45 ›› Issue (8) : 987 -989. DOI: 10.1002/cac2.70037

LETTER TO THE JOURNAL

Cell-free DNA blood-based test compared to fecal immunochemical test for colorectal cancer screening

Author information +

History +

PDF

Cite this article

Download citation ▾

Teresa Seum, Michael Hoffmeister, Hermann Brenner. Cell-free DNA blood-based test compared to fecal immunochemical test for colorectal cancer screening. Cancer Communications, 2025, 45(8): 987-989 DOI:10.1002/cac2.70037

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021; 325(19): 1978-98.

[2]	Ladabaum U, Mannalithara A, Weng Y, Schoen RE, Dominitz JA, Desai M, et al. Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy. Gastroenterology. 2024; 167(2): 378-91.

[3]	Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol. 2022; 19(8): 521-31.

[4]	Ola I, Cardoso R, Hoffmeister M, Brenner H. Utilization of colorectal cancer screening tests across European countries: a cross-sectional analysis of the European health interview survey 2018-2020. Lancet Reg Health Eur. 2024; 41: 100920.

[5]	Chung DC, Gray DM, Singh H, Issaka RB, Raymond VM, Eagle C, et al. A cell-free DNA blood-based test for colorectal cancer screening. New England Journal of Medicine. 2024; 390(11): 973-83.

[6]	Seum T, Niedermaier T, Heisser T, Hoffmeister M, Brenner H. Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening. JAMA Internal Medicine. 2025; 185(1): 110-2.

[7]	Imperiale TF, Porter K, Zella J, Gagrat ZD, Olson MC, Statz S, et al. Next-generation multitarget stool DNA test for colorectal cancer screening. New England Journal of Medicine. 2024; 390(11): 984-93.

[8]	Barnell EK, Wurtzler EM, La Rocca J, Fitzgerald T, Petrone J, Hao Y, et al. Multitarget Stool RNA Test for Colorectal Cancer Screening. JAMA. 2023; 330(18): 1760-8.

[9]	Niedermaier T, Seum T, Hoffmeister M, Brenner H. Lowering Fecal Immunochemical Test Positivity Threshold vs Multitarget Stool RNA Testing for Colorectal Cancer Screening. JAMA. 2024; 332(3): 251-2.

[10]	van den Puttelaar R, Nascimento de Lima P, Knudsen AB, Rutter CM, Kuntz KM, de Jonge L, et al. Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision. Gastroenterology. 2024; 167(2): 368-77.